Let's talk medical research

We’re here with Antidote’s tenth installment of Talk of the Towne, and it’s a very special one! We recently attended SCOPE 2024, where we met up with our partners at Rare Patient Voice and recorded our first Talk of the Towne episode live and in person.

Individuals living with an illness are likely well-versed in the art of discussing difficult topics with their family and friends. However, for those who are considering taking part in a clinical trial, there may be extra questions to consider when sharing their intent to enroll.

Behind every new treatment is the incredible team of doctors, researchers, patients, and clinical trial specialists who worked on the research that made it possible. Because every therapy must be rigorously tested through clinical trials before it can be approved, the process from creation to entering the market can be an arduous one — but it’s one that makes medical breakthroughs possible.

While effectively recruiting patients is a necessary part of every study, it can also incur significant costs. Patient recruitment is one of the largest budget categories in a clinical trial, but often, this is due to ineffective outreach methods and expensive screen failures that contribute to excessive spending.

In the human eye, the cornea's function is to refract light onto the lens and retina to maintain vision function — but this role is dependent on the corneal epithelium’s ability to renew itself continually. The corneal epithelium provides a barrier to protect the interior of the cornea from damage, but when it becomes injured, this function becomes impaired.

A common problem in the clinical trial industry is finding enough interested individuals to take part in a study. However, keeping patients at the center of clinical trial marketing is one of the most effective ways to address this issue. Having a deep understanding of the patient experience and considering what patients want and need from research (otherwise known as a patient-centric approach) ...

Making use of electronic patient-reported outcomes (otherwise known as ePRO) can provide a streamlined way to offer a more patient-centric experience and reduce the burden of site staff. Modern ePRO vendors can provide a range of features for clinical trial participants, communicate seamlessly with Interactive Web Response Systems, and provide support services throughout the trial.

We’re excited to share that we’ll be in attendance for the 15th annual SCOPE conference! The conference takes place in Orlando, Florida from February 11th to 14th, and will bring together some of the top companies in the clinical ops industry today.

Endometrial cancer, also known as endometrial carcinoma or uterine cancer, is a condition that approximately 66,000 individuals are diagnosed with annually, and instances rise roughly 2% in the United States each year. Because it is often caught early, a person’s prognosis is typically good — but it is still a disheartening diagnosis that significantly impacts the lives of those who experience it.

Facilitating medical research relies on patient participation, yet research protocols often overlook the patient perspective. Improving patient centricity in clinical trials demands prioritizing the patient experience.